WallStreetZenWallStreetZen

NASDAQ: IFRX
Inflarx Nv Stock Forecast, Predictions & Price Target

Analyst price target for IFRX

Based on 2 analysts offering 12 month price targets for Inflarx Nv.
Min Forecast
$8.00+475.54%
Avg Forecast
$13.50+871.22%
Max Forecast
$19.00+1,266.91%

Should I buy or sell IFRX stock?

Based on 2 analysts offering ratings for Inflarx Nv.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their IFRX stock forecasts and price targets.

IFRX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-22
lockedlocked$00.00+00.00%2023-11-02

1 of 1

Forecast return on equity

Is IFRX forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.16%

Forecast return on assets

Is IFRX forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

IFRX revenue forecast

What is IFRX's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$6.2M+8,720.51%
Avg 2 year Forecast
$9.4M+13,332.62%
Avg 3 year Forecast
$61.2M+87,135.01%
IFRX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

IFRX revenue growth forecast

How is IFRX forecast to perform vs Biotechnology companies and vs the US market?
Company
799.8%
Industry
37.04%
Market
9.92%
IFRX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
IFRX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

IFRX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
IFRX$1.39$13.50+871.22%Strong Buy
LPTX$3.17$11.38+258.83%Strong Buy
RVPH$2.98$16.33+448.09%Strong Buy
ONCY$1.08$4.00+270.37%Buy
ATRA$0.70$1.27+81.00%Sell

Inflarx Nv Stock Forecast FAQ

Is Inflarx Nv Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: IFRX) stock is to Strong Buy IFRX stock.

Out of 2 analysts, 1 (50%) are recommending IFRX as a Strong Buy, 1 (50%) are recommending IFRX as a Buy, 0 (0%) are recommending IFRX as a Hold, 0 (0%) are recommending IFRX as a Sell, and 0 (0%) are recommending IFRX as a Strong Sell.

If you're new to stock investing, here's how to buy Inflarx Nv stock.

What is IFRX's revenue growth forecast for 2024-2026?

(NASDAQ: IFRX) Inflarx Nv's forecast annual revenue growth rate of 799.8% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.04%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.92%.

Inflarx Nv's revenue in 2024 is $68,575.On average, 3 Wall Street analysts forecast IFRX's revenue for 2024 to be $364,075,271, with the lowest IFRX revenue forecast at $40,040,625, and the highest IFRX revenue forecast at $965,096,828. On average, 3 Wall Street analysts forecast IFRX's revenue for 2025 to be $554,444,889, with the lowest IFRX revenue forecast at $118,944,209, and the highest IFRX revenue forecast at $1,399,066,543.

In 2026, IFRX is forecast to generate $3,600,712,083 in revenue, with the lowest revenue forecast at $203,736,121 and the highest revenue forecast at $6,997,688,044.

What is IFRX's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: IFRX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is IFRX's Price Target?

According to 2 Wall Street analysts that have issued a 1 year IFRX price target, the average IFRX price target is $13.50, with the highest IFRX stock price forecast at $19.00 and the lowest IFRX stock price forecast at $8.00.

On average, Wall Street analysts predict that Inflarx Nv's share price could reach $13.50 by Mar 22, 2025. The average Inflarx Nv stock price prediction forecasts a potential upside of 871.22% from the current IFRX share price of $1.39.

What is IFRX's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: IFRX) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.